{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:58:18Z","timestamp":1792785498463,"version":"4.5.0"},"reference-count":104,"publisher":"Informa UK Limited","issue":"3","funder":[{"name":"none","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"published-print":{"date-parts":[[2019,3,4]]},"DOI":"10.1080\/17425255.2019.1574744","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T19:33:26Z","timestamp":1548358406000},"page":"231-244","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":86,"title":["Hepatotoxicity induced by immune checkpoint inhibitors: a comprehensive review including current and alternative management strategies"],"prefix":"10.1080","volume":"15","author":[{"given":"Joseph J.","family":"Jennings","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, MedStar Georgetown University Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Mandaliya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, MedStar Georgetown University Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Nakshabandi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mercy Hospital and Medical Center, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology and Hepatology, MedStar Georgetown University Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"CIT0001","first-page":"137","volume":"5","author":"Busch W.","year":"1868","journal-title":"Berl Klin Wochenschr"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1196806"},{"key":"CIT0003","first-page":"154","volume":"26","author":"McCarthy EF","year":"2006","journal-title":"Iowa Orthop J"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.4049\/jimmunol.129.5.2293","volume":"129","author":"Allison JP","year":"1982","journal-title":"J Immunol"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1126\/science.1840703"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5256.1734"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.18.00005"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx225"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-018-1259-6"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0346-6"},{"issue":"2","key":"CIT0014","first-page":"27","volume":"43","author":"Moore C","year":"2018","journal-title":"US Pharm"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12531"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s11901-018-0408-8"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30678"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2002.18809.x"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2051"},{"issue":"12","key":"CIT0020","first-page":"4296","volume":"9","author":"Nagorsen D","year":"2003","journal-title":"Clin Cancer Res"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/857519"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.2.1052"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxp072"},{"key":"CIT0024","volume-title":"Targeted therapies in cancer","author":"Lacroix M","year":"2014"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0653-8"},{"issue":"8","key":"CIT0026","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1634\/theoncologist.2009-0028","volume":"14","author":"Robert C","year":"2009","journal-title":"Oncologist"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2010.09.003"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31817150e3"},{"issue":"8","key":"CIT0029","doi-asserted-by":"crossref","first-page":"viii433","DOI":"10.1093\/annonc\/mdy288.093","volume":"29","author":"Shah N","year":"2018","journal-title":"Ann Oncol"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104621"},{"key":"CIT0032","volume-title":"Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB\/IV non\u2013small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study","author":"Lynch TJ","year":"2018"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds213"},{"key":"CIT0034","volume-title":"Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial","author":"Kwon ED"},{"key":"CIT0035","volume-title":"Ipilimumab versus placebo after complete resection of stage III melanoma: initial efficacy and safety results from the EORTC 18071 phase III trial","author":"Eggermont AM"},{"key":"CIT0036","doi-asserted-by":"crossref","volume-title":"Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma","author":"Ribas A","DOI":"10.1200\/JCO.2012.44.6112"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412082"},{"key":"CIT0038","volume-title":"Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma","author":"Weber JS","year":"2017"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643"},{"key":"CIT0041","volume-title":"Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial","author":"Rosenberg JE"},{"key":"CIT0042","volume-title":"IMpower131: primary PFS and safety analysis of a randomized phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin+ nab-paclitaxel as 1L therapy in advanced squamous NSCLC","author":"Jotte RM","year":"2018"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414428"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302369"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.08.014"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2017.04.003"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13746"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0300-z"},{"key":"CIT0051","author":"Wang DY","journal-title":"JAMA Oncol"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1533209100"},{"key":"CIT0053","volume-title":"MDX010\u201020 Investigators. Patterns of onset and resolution of immune\u2010related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma","author":"Weber JS"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.41.6750"},{"key":"CIT0055","volume-title":"Yervoy (Ipilimumab) [Package Insert]","year":"2017"},{"key":"CIT0056","volume-title":"Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study","author":"Wolchok JD"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1302338"},{"key":"CIT0058","volume-title":"Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)","author":"Schachter J"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1159\/000486679"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.02.003"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.6212"},{"key":"CIT0062","volume-title":"Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial","author":"Ribas A"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00730"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.01.033"},{"key":"CIT0065","author":"Huffman BM","journal-title":"Am J Clin Oncol"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0013-y"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2140-5"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000453"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-013-9939-6"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000759"},{"key":"CIT0071","first-page":"1028","volume-title":"Schiff\u2019s disease of the liver","author":"Lewis JH","year":"2018","edition":"12"},{"issue":"1","key":"CIT0072","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1665-2681(19)31396-1","volume":"12","author":"Aguilar-Olivos N","year":"2013","journal-title":"Ann Hepatol"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(80)80105-5"},{"key":"CIT0074","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41424-018-0049-9","volume":"9","author":"Reddy HG","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000268"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-017-0453-0"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23588"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.05.027"},{"key":"CIT0079","author":"Mart\u00ednez\u2010Casas OY","journal-title":"JGH Open"},{"key":"CIT0080","first-page":"13","volume":"28","author":"Wang H","year":"2017","journal-title":"Biomed Res"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.09.024"},{"issue":"1","key":"CIT0082","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/JIPO.JIPO_12_18","author":"Abu-Sbeih H","year":"2018","journal-title":"J Immunother Precis Oncol"},{"key":"CIT0083","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.1167"},{"issue":"2","key":"CIT0084","first-page":"1006","volume":"1","author":"Sarmen S","year":"2016","journal-title":"Austin Oncol"},{"issue":"2","key":"CIT0085","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/annonc\/mdw443","volume":"28","author":"Menzies AM","year":"2016","journal-title":"Ann Oncol"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.4368"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.7326\/M17-2073"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2017.08.14"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.2206"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.034"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx642"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.11.015"},{"key":"CIT0096","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.046"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1245"},{"key":"CIT0098","doi-asserted-by":"publisher","DOI":"10.1038\/nri2343"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20649"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2035"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-014-0033-1"},{"key":"CIT0102","volume-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial","author":"El-Khoueiry AB","year":"2000"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.10.039"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx502"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-201211271-00421"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.1177\/2050640618774631"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1614298"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.01.063"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.06.012"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.10.020"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.60.8448"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2019.1574744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T01:01:20Z","timestamp":1694566880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2019.1574744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":104,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2,11]]},"published-print":{"date-parts":[[2019,3,4]]}},"alternative-id":["10.1080\/17425255.2019.1574744"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2019.1574744","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-10-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}